Jacqueline Claire Lupo
Directeur Général chez LOPHOS HOLDINGS INC.
Fortune : 440 000 $ au 31/05/2024
Postes actifs de Jacqueline Claire Lupo
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| LOPHOS HOLDINGS INC. | Directeur/Membre du Conseil | 23/12/2021 | - |
| Directeur Général | 23/12/2021 | - | |
Lophos Pharmaceuticals Corp.
 Lophos Pharmaceuticals Corp. BiotechnologyHealth Technology Part of Lophos Holdings, Inc., Lophos Pharmaceuticals Corp. is a Canadian biosciences company that specializes in peyote cultivation, research, and sale. The company is also licensed to possess, sell/provide, send, transport and deliver controlled substances covered by their controlled substances dealers license (CSDL), namely mescaline, psilocin, psilocybin, LSD, DMT, and ketamine, as well as produce mescaline, psilocin, and psilocybin. Lophos Pharmaceuticals was acquired by Greenridez 2.0 Acquisitions Corp. on January 21, 2022. | Directeur/Membre du Conseil | 01/01/2021 | - |
| Directeur Général | 01/09/2021 | - | |
| Fondateur | 01/01/2021 | - | |
| President | 01/09/2021 | - | |
| Northern Green Canada, Inc. | Corporate Officer/Principal | - | - |
Historique de carrière de Jacqueline Claire Lupo
Anciens postes connus de Jacqueline Claire Lupo
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| Canalytica Corp. | Fondateur | - | - |
Statistiques
Internationale
| Canada | 4 |
| 2 |
Opérationnelle
| Director/Board Member | 2 |
| Chief Executive Officer | 2 |
| Founder | 2 |
Sectorielle
| Health Technology | 2 |
| Consumer Non-Durables | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Entreprise privées | 4 |
|---|---|
| Lophos Holdings, Inc. | |
Lophos Pharmaceuticals Corp.
Lophos Pharmaceuticals Corp. BiotechnologyHealth Technology Part of Lophos Holdings, Inc., Lophos Pharmaceuticals Corp. is a Canadian biosciences company that specializes in peyote cultivation, research, and sale. The company is also licensed to possess, sell/provide, send, transport and deliver controlled substances covered by their controlled substances dealers license (CSDL), namely mescaline, psilocin, psilocybin, LSD, DMT, and ketamine, as well as produce mescaline, psilocin, and psilocybin. Lophos Pharmaceuticals was acquired by Greenridez 2.0 Acquisitions Corp. on January 21, 2022. | Health Technology |
| Northern Green Canada, Inc. | Consumer Non-Durables |
| Canalytica Corp. |
- Bourse
- Insiders
- Jacqueline Claire Lupo
- Expérience
